Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership3,118,124 shares
Latest Disclosed Value $ 11,162,884
Millennium Management Llc ownership in 9IP1 / Rocket Pharmaceuticals, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 3,118,124 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $8,777,519 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,784,921 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 74.69% during the quarter. The current value of the position is $7,608,223 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (9IP1) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9IP1 / Rocket Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 3,118,124 1,333,203 74.69 11,163 78.16 0.0046
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,784,921 -1,785,470 -50.01 6,265 -46.17 0.0026
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 3,570,391 1,221,554 52.01 11,639 102.28 0.0050
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,348,837 1,601,690 214.37 5,755 15.47 0.0028
2025-05-15 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 747,147 410,238 121.77 4,983 17.69 0.0027
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 336,909 -865,586 -71.98 4,235 -80.94 0.0021
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,202,495 1,097,170 1,041.70 22,210 879.71 0.0105
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 105,325 105,325 2,268 0.0011
2024-05-15 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -54,865 -100.00 0 -100.00
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 54,865 -950,943 -94.55 1,644 -92.02 0.0007
2023-11-14 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,005,808 826,592 461.23 20,609 478.74 0.0104
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 179,216 179,216 3,561 0.0018
2023-02-14 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -220,586 -100.00 0 -100.00
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 220,586 122,976 125.99 3,521 162.17 0.0021
2022-08-15 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 97,610 74,545 323.20 1,343 266.94 0.0008
2022-05-16 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 23,065 -197,948 -89.56 366 -92.41 0.0002
2022-02-14 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 221,013 221,013 4,825 0.0025
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -124,560 -100.00 0 -100.00
2021-05-17 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 124,560 -111,658 -47.27 5,527 -57.33 0.0040
2021-02-16 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 236,218 194,126 461.19 12,954 1,246.57 0.0094
2020-11-16 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 42,092 -162,904 -79.47 962 -77.58 0.0012
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 204,996 204,996 4,291 0.0059
2020-05-14 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -96,702 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 96,702 48,339 99.95 2,201 290.94 0.0028
2019-11-14 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 48,363 -532,761 -91.68 563 -93.54 0.0009
2019-08-15 2019-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 581,124 124,538 27.28 8,717 8.84 0.0131
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 581,124 124,538 8,717
2019-05-14 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 456,586 395,124 642.88 8,009 779.14 0.0120
2019-02-15 2018-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 61,462 -80,041 -56.56 911 -73.85 0.0014
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 61,462 911
2018-11-14 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 141,503 48,341 51.89 3,484 90.49 0.0043
2018-08-14 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 93,162 37,656 67.84 1,829 75.70 0.0024
2018-05-15 2018-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 55,506 55,506 1,041 0.0014
2018-02-14 2017-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -201,509 -100.00 0 -100.00
2017-11-14 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 201,509 -14,373 -6.66 359 -12.44 0.0005
2017-08-14 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 215,882 113,454 110.76 410 100.00 0.0007
2017-05-15 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 102,428 -424,853 -80.57 205 -93.63 0.0004
2017-02-14 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 527,281 169,493 47.37 3,216 -5.19 0.0067
2016-11-14 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 357,788 219,722 159.14 3,392 230.28 0.0057
2016-08-15 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 138,066 101,174 274.24 1,027 276.19 0.0024
2016-05-16 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 36,892 19,480 111.88 273 38.58 0.0007
2016-02-16 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 17,412 17,412 197 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ROCKET PHARMACEUTICALS COM Call 20,000 539 n/a n/a n/a
2021-02-16 2020-12-31 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F ROCKET PHARMACEUTICALS COM Call 12,800 -84.48 293 -41.75 n/a n/a n/a
2017-02-14 2016-12-31 13F INOTEK PHARMACEUTICALS COM Call 82,500 503 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F ROCKET PHARMACEUTICALS COM Put 20,000 887 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.